Cargando…
Targeting CXCR4-expressing Cancer Cells with Avidin-poly (lactic-co-glycolic acid) Nanoparticle Surface Modified with Biotinylated DV1 Peptide
BACKGROUND: Chemokine receptor CXCR4 is frequently present in cells of various cancers. Hence, targeted therapy using CXCR4 ligands, such as DV1 peptide, on drug-loaded nanoparticles, has the potential to enhance the efficiency of cancer treatment. AIM: The present study created a CXCR4-targeting dr...
Autores principales: | Ansari, Shiba, Mudassir, Madeeha, Vijayalekshmi, B., Chattopadhyay, Parthaprasad |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer - Medknow
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10443452/ https://www.ncbi.nlm.nih.gov/pubmed/37614837 http://dx.doi.org/10.4103/ijabmr.ijabmr_58_23 |
Ejemplares similares
-
The Biotin–Avidin Interaction in Biotinylated Gold Nanoparticles and the Modulation of Their Aggregation
por: Lyu, Yanchao, et al.
Publicado: (2021) -
Comparison of the Chase Effects of Avidin, Streptavidin, Neutravidin, and Avidin‐Ferritin on a Radiolabeled Biotinylated Anti‐tumor Monoclonal Antibody
por: Kobayashi, Hisataka, et al.
Publicado: (1995) -
Distribution of neocarzinostatin conjugated to biotinylated chimeric monoclonal antibody Fab fragments after administration of avidin.
por: Otsuji, E., et al.
Publicado: (1996) -
Differentiation between temporary and real non-clearability of biotinylated IgG antibody by avidin in mice
por: Dou, Shuping, et al.
Publicado: (2014) -
Decreased Renal Accumulation of Biotinylated Chimeric Monoclonal Antibody‐Neocarzinostatin Conjugate after Administration of Avidin
por: Otsuji, Eigo, et al.
Publicado: (1997)